Skip Navigation

This Article
Right arrow Print PDF (1200K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (126)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Mermer, B.
Right arrow Articles by Pavlakis, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mermer, B.
Right arrow Articles by Pavlakis, G. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1990, Vol. 18, No. 8 2037-2044
© 1990


MOLECULAR BIOLOGY

Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells

Brion Mermer, Barbara K. Felber, Mel Campbell and George N. Pavlakis*

National Cancer Institute-Frederick Cancer Research Facility, BRI-Basic Research Program Frederick, MD, 21701-1013, USA

* To whom correspondence should be addressed at National Cancer Institute, Frederick Cancer Research Facility, BRI-Basic Research Program, PO Box B/Building 539 Room 121, Frederick, MD 21701-1013, USA

Received January 3, 1990. Revised March 19, 1990. Accepted March 19, 1990.

A synthetic rev gene containing substitutions which introduced unique restriction sites but did not alter the deduced amino acid sequence was used as a vehicle to construct mutations in rev. Insertion or substitution mutations within a domain of Revresulted in proteins able to inhibit the function of Revprotein in trans. Rev function was monitored in a cell line, HLfB, which contained a rev mutant provirus. HLfB cells require the presence of rev for virus production, which was conveniently monitored by immunoblot detection of p24gag. Trans-dominant mutants were identified after expression in bacteria and delivery into HLfB cells by protoplast fusion. In addition, the trans-dominant phenotype was verified by expression of the mutant proteins in HLfB cells after cotransfection. These studies define a region between amino acid residues 81 and 88 of rev, in which different mutations result in proteins capable of inhibiting Rev function.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Daelemans, S. V. Costes, E. H. Cho, R. A. Erwin-Cohen, S. Lockett, and G. N. Pavlakis
In Vivo HIV-1 Rev Multimerization in the Nucleolus and Cytoplasm Identified by Fluorescence Resonance Energy Transfer
J. Biol. Chem., November 26, 2004; 279(48): 50167 - 50175.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Hakata, M. Yamada, N. Mabuchi, and H. Shida
The Carboxy-Terminal Region of the Human Immunodeficiency Virus Type 1 Protein Rev Has Multiple Roles in Mediating CRM1-Related Rev Functions
J. Virol., July 17, 2002; 76(16): 8079 - 8089.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Magin-Lachmann, S. Hahn, H. Strobel, U. Held, J. Lower, and R. Lower
Rec (Formerly Corf) Function Requires Interaction with a Complex, Folded RNA Structure within Its Responsive Element rather than Binding to a Discrete Specific Binding Site
J. Virol., November 1, 2001; 75(21): 10359 - 10371.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y.-S. Nam, A. Petrovic, K.-S. Jeong, and S. Venkatesan
Exchange of the Basic Domain of Human Immunodeficiency Virus Type 1 Rev for a Polyarginine Stretch Expands the RNA Binding Specificity, and a Minimal Arginine Cluster Is Required for Optimal RRE RNA Binding Affinity, Nuclear Accumulation, and trans-Activation
J. Virol., March 15, 2001; 75(6): 2957 - 2971.
[Abstract] [Full Text]


Home page
J. Virol.Home page
D. M. D'Agostino, T. Ferro, L. Zotti, F. Meggio, L. A. Pinna, L. Chieco-Bianchi, and V. Ciminale
Identification of a Domain in Human Immunodeficiency Virus Type 1 Rev That Is Required for Functional Activity and Modulates Association with Subnuclear Compartments Containing Splicing Factor SC35
J. Virol., December 15, 2000; 74(24): 11899 - 11910.
[Abstract] [Full Text]


Home page
J. Virol.Home page
C. Magin, R. Lower, and J. Lower
cORF and RcRE, the Rev/Rex and RRE/RxRE Homologues of the Human Endogenous Retrovirus Family HTDV/HERV-K
J. Virol., November 1, 1999; 73(11): 9496 - 9507.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Ludwig, F. C. Silberstein, J. van Empel, V. Erfle, M. Neumann, and R. Brack-Werner
Diminished Rev-Mediated Stimulation of Human Immunodeficiency Virus Type 1 Protein Synthesis Is a Hallmark of Human Astrocytes
J. Virol., October 1, 1999; 73(10): 8279 - 8289.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Bear, W. Tan, A. S. Zolotukhin, C. Tabernero, E. A. Hudson, and B. K. Felber
Identification of Novel Import and Export Signals of Human TAP, the Protein That Binds to the Constitutive Transport Element of the Type D Retrovirus mRNAs
Mol. Cell. Biol., September 1, 1999; 19(9): 6306 - 6317.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Calarota, A.-C. Leandersson, G. Bratt, J. Hinkula, D. M. Klinman, K. J. Weinhold, E. Sandstrom, and B. Wahren
Immune Responses in Asymptomatic HIV-1-Infected Patients After HIV-DNA Immunization Followed by Highly Active Antiretroviral Treatment
J. Immunol., August 15, 1999; 163(4): 2330 - 2338.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. M. Szilvay, S.-O. Bøe, and K.-H. Kalland
Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs
J. Gen. Virol., August 1, 1999; 80(8): 1965 - 1974.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. I. Van Ryk and S. Venkatesan
Real-time Kinetics of HIV-1 Rev-Rev Response Element Interactions. DEFINITION OF MINIMAL BINDING SITES ON RNA AND PROTEIN AND STOICHIOMETRIC ANALYSIS
J. Biol. Chem., June 18, 1999; 274(25): 17452 - 17463.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Li, H. Tang, T.-M. Mullen, C. Westberg, T. R. Reddy, D. W. Rose, and F. Wong-Staal
A role for RNA helicase A in post-transcriptional regulation of HIV type 1
PNAS, January 19, 1999; 96(2): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Askjaer, T. H. Jensen, J. Nilsson, L. Englmeier, and J. Kjems
The Specificity of the CRM1-Rev Nuclear Export Signal Interaction Is Mediated by RanGTP
J. Biol. Chem., December 11, 1998; 273(50): 33414 - 33422.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. L. Thomas, M. Oft, H. Jaksche, G. Casari, P. Heger, M. Dobrovnik, D. Bevec, and J. Hauber
Functional Analysis of the Human Immunodeficiency Virus Type 1 Rev Protein Oligomerization Interface
J. Virol., April 1, 1998; 72(4): 2935 - 2944.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. E. Pasquinelli, M. A. Powers, E. Lund, D. Forbes, and J. E. Dahlberg
Inhibition of mRNA export in vertebrate cells by nuclear export signal conjugates
PNAS, December 23, 1997; 94(26): 14394 - 14399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. S. Zolotukhin and B. K. Felber
Mutations in the Nuclear Export Signal of Human Ran-binding Protein RanBP1 Block the Rev-mediated Posttranscriptional Regulation of Human Immunodeficiency Virus Type 1
J. Biol. Chem., April 25, 1997; 272(17): 11356 - 11360.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
B E Meyer and M H Malim
The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm.
Genes & Dev., July 1, 1994; 8(13): 1538 - 1547.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.